Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.
CompletedNCT05749055
ENX-102 for anxiety
This study is completed in the United States. It is testing ENX-102 for anxiety.
AnxietyDrugFrom 18 Years to 65 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
Check the study details
Check the official source, then confirm these points with the research team.
View official study record (opens in a new tab)
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateStarted: July 3, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 252
- Sponsor
- Engrail Therapeutics INC
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05749055
- Official title
- The ENCALM Trial: A Randomized, Double-blind, Placebo-controlled Monotherapy Trial to Evaluate the Efficacy and Safety of ENX-102 in Patients With Generalized Anxiety Disorder
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT05749055. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
View official study record (opens in a new tab)The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
United States · 32 sites
- IMA Clinical Research PhoenixPhoenix, ArizonaSite status: Not listed — confirm with the team
- Collaborative Neuroscience Research, LLC (CNS)Garden Grove, CaliforniaSite status: Not listed — confirm with the team
- Sun Valley Research CenterImperial, CaliforniaSite status: Not listed — confirm with the team
- Alliance ResearchLong Beach, CaliforniaSite status: Not listed — confirm with the team
- NRC Research InstituteLos Angeles, CaliforniaSite status: Not listed — confirm with the team
- Excell Research, Inc.Oceanside, CaliforniaSite status: Not listed — confirm with the team
- Anderson Clinical ResearchRedlands, CaliforniaSite status: Not listed — confirm with the team
- California Neuroscience Research, LLCSherman Oaks, CaliforniaSite status: Not listed — confirm with the team
- Pacific Clinical Research Management GroupUpland, CaliforniaSite status: Not listed — confirm with the team
- Sunwise Clinical ResearchWalnut Creek, CaliforniaSite status: Not listed — confirm with the team
- Mountain View Clinical ResearchDenver, ColoradoSite status: Not listed — confirm with the team
- Vertex Clinical ResearchClermont, FloridaSite status: Not listed — confirm with the team
- Clinical Neuroscience Solutions, Inc.Jacksonville, FloridaSite status: Not listed — confirm with the team
- Accel Research Sites Network - Lakeland CRULakeland, FloridaSite status: Not listed — confirm with the team
- Accel Research Sites Network - Maitland CRUMaitland, FloridaSite status: Not listed — confirm with the team
- Clinical Neuroscience Solutions, Inc.Orlando, FloridaSite status: Not listed — confirm with the team
- CenExel iResearch, LLCSavannah, GeorgiaSite status: Not listed — confirm with the team
- Collective Medical ResearchOverland Park, KansasSite status: Not listed — confirm with the team
- Boston Clinical TrialsBoston, MassachusettsSite status: Not listed — confirm with the team
- Precise Research CentresFlowood, MississippiSite status: Not listed — confirm with the team
- IMA Clinical ResearchLas Vegas, NevadaSite status: Not listed — confirm with the team
- SPRI Clinical Trials, LLCBrooklyn, New YorkSite status: Not listed — confirm with the team
- Neurobehavioral ResearchCedarhurst, New YorkSite status: Not listed — confirm with the team
- Richmond Behavioral AssociatesStaten Island, New YorkSite status: Not listed — confirm with the team
- Clinical Neuroscience Solutions, Inc.Memphis, TennesseeSite status: Not listed — confirm with the team
- Austin Clinical Trials PartnersAustin, TexasSite status: Not listed — confirm with the team
- FutureSearch Trials of DallasDallas, TexasSite status: Not listed — confirm with the team
- Baylor College of MedicineHouston, TexasSite status: Not listed — confirm with the team
- Aim TrialsPlano, TexasSite status: Not listed — confirm with the team
- Grayline Research CenterWichita Falls, TexasSite status: Not listed — confirm with the team
- Alpine Research OrganizationClinton, UtahSite status: Not listed — confirm with the team
- Core Clinical ResearchEverett, WashingtonSite status: Not listed — confirm with the team
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with anxiety. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving ENX-102, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.
Who might this study be for?
This study may concern people with anxiety; age range: From 18 Years to 65 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Engrail Therapeutics INC, which appears to be a biotech company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT05729373
A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder
This study is completed in the United States, in Bulgaria, in Estonia, .... It focuses on anxiety.
CompletedNCT05407064
A Dose-Finding Study of MM120 (LSD D-Tartrate) for Anxiety Symptoms
This study is completed. It focuses on anxiety and currently lists study information in the United States.
CompletedNCT01996644
A Double Blind study of DCS for Food Anxiety
This study is completed. It focuses on eating disorders and currently lists study information in the United States.